Empiric Antibiotic Choices for Pediatric Patients
For most common pediatric infections, high-dose amoxicillin (90 mg/kg/day) is the preferred first-line empiric antibiotic, with specific modifications based on age, immunization status, local resistance patterns, and infection severity.
Community-Acquired Pneumonia (CAP)
Outpatient Treatment
Children < 5 years (preschool):
- First-line: Oral amoxicillin 90 mg/kg/day divided in 2 doses 1
- Alternative: Amoxicillin-clavulanate (amoxicillin component 90 mg/kg/day in 2 doses) 1
- For atypical pneumonia: Azithromycin 10 mg/kg on day 1, then 5 mg/kg/day once daily on days 2-5 1
- Duration: 5 days is as effective as 10 days for uncomplicated CAP 2
Children ≥ 5 years:
- First-line: Oral amoxicillin 90 mg/kg/day in 2 doses (maximum 4 g/day) 1
- If atypical pathogens cannot be distinguished: Add a macrolide to β-lactam therapy 1
- For confirmed atypical pneumonia: Azithromycin 10 mg/kg day 1 (max 500 mg), then 5 mg/kg days 2-5 (max 250 mg) 1
- Alternative for children > 7 years: Doxycycline 2-4 mg/kg/day in 2 doses 1
Inpatient Treatment
Fully immunized children (Hib and pneumococcal vaccines) in areas with minimal penicillin resistance:
- First-line: IV ampicillin 150-200 mg/kg/day every 6 hours OR IV penicillin G 200,000-250,000 U/kg/day every 4-6 hours 1
- Alternatives: Ceftriaxone 50-100 mg/kg/day every 12-24 hours OR cefotaxime 150 mg/kg/day every 8 hours 1
Not fully immunized OR high local penicillin resistance OR life-threatening infection:
- First-line: Ceftriaxone 50-100 mg/kg/day every 12-24 hours OR cefotaxime 150 mg/kg/day every 8 hours 1
- Add for suspected CA-MRSA: Vancomycin 40-60 mg/kg/day every 6-8 hours OR clindamycin 40 mg/kg/day every 6-8 hours (based on local susceptibility) 1
If atypical pathogens suspected (M. pneumoniae, C. pneumoniae):
- Add to β-lactam: IV azithromycin 10 mg/kg on days 1-2, then transition to oral 1
Acute Otitis Media (AOM)
First-line: Oral amoxicillin 90 mg/kg/day in 2 doses 1, 3
- Duration: 5 days for children ≥ 2 years with uncomplicated AOM 4
- Duration: 10 days for children < 2 years 4
If β-lactamase-producing organisms suspected:
- Amoxicillin-clavulanate (amoxicillin component 90 mg/kg/day in 2 doses) 1
Deferred prescribing: Consider for children ≥ 2 years with non-severe symptoms, providing prescription to fill only if symptoms worsen or fail to improve in 48-72 hours 4
Skin and Soft Tissue Infections (SSTI)
Methicillin-susceptible S. aureus (MSSA):
- Outpatient: Oral cephalexin 75-100 mg/kg/day in 3-4 doses 1
- Inpatient: IV cefazolin 150 mg/kg/day every 8 hours OR IV oxacillin 150-200 mg/kg/day every 6-8 hours 1
Suspected CA-MRSA (clindamycin-susceptible):
- Outpatient: Oral clindamycin 30-40 mg/kg/day in 3-4 doses 1
- Inpatient: IV vancomycin 40-60 mg/kg/day every 6-8 hours (target AUC/MIC >400) OR IV clindamycin 40 mg/kg/day every 6-8 hours 1
CA-MRSA (clindamycin-resistant):
- Outpatient: Oral linezolid 30 mg/kg/day in 3 doses (children <12 years) OR 20 mg/kg/day in 2 doses (children ≥12 years) 1
- Inpatient: IV vancomycin 40-60 mg/kg/day every 6-8 hours 1
Uncomplicated Urinary Tract Infection (UTI)
While the provided evidence focuses primarily on respiratory and skin infections, standard practice for uncomplicated UTI in children includes:
- First-line: Oral cephalexin, cefixime, or trimethoprim-sulfamethoxazole (based on local resistance patterns)
- Duration: 7-10 days for cystitis; 10-14 days for pyelonephritis
Bacterial Meningitis
Infants < 5 weeks:
- First-line: IV ampicillin PLUS IV ceftriaxone or cefotaxime 5
- Alternative: IV ampicillin PLUS IV aminoglycoside (gentamicin) 5
Children 5 weeks to 12 years:
- First-line: IV ceftriaxone 100 mg/kg/day every 12-24 hours OR IV cefotaxime 150 mg/kg/day every 8 hours 5
- Consider adding: IV vancomycin 40-60 mg/kg/day every 6-8 hours if highly resistant pneumococcus suspected 1
- Adjunctive therapy: Dexamethasone for children ≥ 2 months with presumed bacterial meningitis 5
Severe Sepsis
Neonates (0-59 days):
- First-line: IV ampicillin PLUS IV gentamicin 3
- Alternative: IV ampicillin PLUS IV ceftriaxone or cefotaxime 6
Children > 2 months:
- First-line: IV ceftriaxone 50-100 mg/kg/day OR IV cefotaxime 150 mg/kg/day 6
- If MRSA suspected: Add IV vancomycin 40-60 mg/kg/day 6
Critical Considerations
Common pitfalls to avoid:
- Excessive antibiotic duration: Most CAP cases require only 5 days of treatment, yet 67% of prescriptions exceed this 4
- Macrolide overuse: Macrolides are not first-line for CAP in children < 5 years unless atypical pathogens are confirmed 7
- Oral third-generation cephalosporins: These should not replace amoxicillin for uncomplicated infections due to inferior efficacy and broader spectrum 3
- Dosing intervals: Amoxicillin should be dosed twice daily (not three times) at 90 mg/kg/day for optimal middle ear and lung penetration 1
Age-specific modifications:
- Children < 2 months with any serious infection require hospitalization and parenteral antibiotics 6
- Doxycycline can be used in children > 7 years for atypical pneumonia 1
- Fluoroquinolones (levofloxacin) are reserved for children with skeletal maturity or macrolide intolerance 1
Local resistance patterns matter: In areas with high-level penicillin resistance in invasive pneumococcus, empiric third-generation cephalosporins are preferred over ampicillin/penicillin 1